Nicholas Focil, un bioquímico de origen ecuatoriano, lidera ensayos clínicos para encontrar un posible tratamiento y vacuna contra el coronavirus en Oxnard, California, con un medicamento considerado "prometedor". LOS ÁNGELES, California.- Centro ...
COVID-19 has unleashed a logistical conundrum for pharma lab leaders: How do you keep momentum in therapeutics development, when, like all workplaces, most labs have had to either restrict use or close altogether? The answer lies, at least in part, i ...
With the U.S. surpassing 2 million cases of COVID-19, infectious disease experts have learned a tremendous amount about SARS-CoV-2's transmissibility, the effects of infection, and how (or how not) to treat it. David Aronoff, MD, of Vanderbilt Uni ...
Researchers in Pittsburgh and Boston are moving forward with research into two separate coronavirus vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine ...
